Insider

Catherine M. Szyman Insider Trading Activity

Every SEC Form 4 transaction reported by Catherine M. Szyman, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Catherine M. Szyman buying or selling?

Catherine M. Szyman reported 1 open-market buys ($533.7K) and 53 sells ($42.1M) across 54 Form 4 filings at 2 companies — a net selling position of $41.6M.

Source: SEC EDGAR Form 4

What stands out

  • Catherine M. Szyman has reported Form 4 transactions at 2 companies; the most active, Edwards Lifesciences Corp (EW), accounts for 53 of 54 filings (98%).
  • The most recent Form 4 was accepted on Feb 15, 2024 (2 years ago).
  • No open-market purchases or sales were reported in the last 12 months.

Key Statistics (as of Feb 15, 2024)

Total Form 4 filings
54
SEC EDGAR
Companies
2
Buys (1)
$533.7K
Sells (53)
$42.1M

Insider sentiment

Net selling

Net insider flow of $41.6M in net selling, filed between May 24, 2018 – Feb 15, 2024.

Companies Catherine M. Szyman files for

#CompanyForm 4 filings
1EWEdwards Lifesciences Corp53
2NARIInari Medical, Inc.1

Recent Catherine M. Szyman transactions

DateTickerRoleTypeSharesValueFiling
Feb 15, 2024EWCVP, Critical CareSale47.0K$4.0MSEC ↗
Oct 10, 2023EWCVP, Critical CareSale5.0K$363.4KSEC ↗
Sep 8, 2023EWCVP, Critical CareSale5.0K$380.0KSEC ↗
Aug 9, 2023EWCVP, Critical CareSale5.0K$393.2KSEC ↗
Jul 10, 2023EWCVP, Critical CareSale5.0K$452.6KSEC ↗
Jun 14, 2023EWCVP, Critical CareSale5.0K$429.0KSEC ↗
May 9, 2023EWCVP, Critical CareSale75.6K$6.7MSEC ↗
May 5, 2022EWCVP, Critical CareSale23.4K$2.5MSEC ↗
Apr 11, 2022EWCVP, Critical CareSale20.0K$2.4MSEC ↗
Mar 14, 2022EWCVP, Critical CareSale20.0K$2.1MSEC ↗
Feb 19, 2022EWCVP, Critical CareSale20.0K$2.1MSEC ↗
Jan 15, 2022EWCVP, Critical CareSale10.0K$1.2MSEC ↗
Dec 18, 2021EWCVP, Critical CareSale10.0K$1.2MSEC ↗
Nov 19, 2021EWCVP, Critical CareSale10.0K$1.2MSEC ↗
Oct 18, 2021EWCVP, Critical CareSale9.7K$1.1MSEC ↗
Sep 9, 2021EWCVP, Critical CareSale9.7K$1.2MSEC ↗
Aug 3, 2021EWCVP, Critical CareSale15.0K$1.7MSEC ↗
Jun 16, 2021EWCVP, Critical CareSale3.4K$345.0KSEC ↗
May 28, 2021EWCVP, Critical CareSale2.1K$196.4KSEC ↗
May 25, 2021EWCVP, Critical CareSale4.7K$448.3KSEC ↗
May 7, 2021EWCVP, Critical CareSale3.4K$311.3KSEC ↗
Apr 23, 2021EWCVP, Critical CareSale3.4K$319.9KSEC ↗
Mar 15, 2021EWCVP, Critical CareSale3.4K$276.7KSEC ↗
Feb 17, 2021EWCVP, Critical CareSale3.4K$298.9KSEC ↗
Jan 16, 2021EWCVP, Critical CareSale3.4K$295.8KSEC ↗

Showing the 25 most recent filings of 54. Screen every filing.

Catherine M. Szyman insider trading FAQ

Is Catherine M. Szyman buying or selling?

Across 54 SEC Form 4 filings, Catherine M. Szyman reported 1 open-market purchases totaling $533.7K and 53 sales totaling $42.1M — a net selling position of $41.6M.

Which companies does Catherine M. Szyman file Form 4s for?

Catherine M. Szyman has reported insider transactions at 2 companies, most often Edwards Lifesciences Corp (EW), Inari Medical, Inc. (NARI).

How far back does Catherine M. Szyman's filing history go?

Trabud holds Catherine M. Szyman's SEC Form 4 filings from May 24, 2018 – Feb 15, 2024, sourced directly from SEC EDGAR.

Where does Trabud get Catherine M. Szyman's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Catherine M. Szyman and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener